Form 4: Intensity Therapeutics Director Emer Leahy Acquires Stock Options
SEC Form 4 Filing
Director Emer Leahy acquired stock options for 50,000 shares of Intensity Therapeutics common stock on March 6, 2024.
Summary
- On March 6, 2024, Emer Leahy, a director of Intensity Therapeutics, Inc., acquired stock options for 50,000 shares of the company's common stock.
- The exercise price of these options is $5.19 per share.
- The options vest in four equal annual installments starting on March 6, 2024, and expire on March 6, 2034.
- Following the transaction, Leahy directly owns 50,000 derivative securities.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock option grants to a director.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. It's common for directors and officers to receive stock options as part of their compensation.
Stakeholder Impact
- The granting of stock options to a director may incentivize them to work towards increasing shareholder value.
Key Dates
| Date | Description |
|---|---|
| 03/06/2024 | Date of transaction: Emer Leahy acquired stock options. |
| 03/06/2024 | Vesting start date: Options vest in four equal annual installments beginning on this date. |
| 03/07/2024 | Date of signature for the Form 4 filing. |
| 03/06/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.